Angola vs Myanmar: Treatment coverage for lymphatic filariasis
Angola
22.6%
in 2024
Myanmar
23.8%
in 2024
Angola rank
49th
Myanmar rank
48th
Treatment coverage for lymphatic filariasis over time
- Angola
- Myanmar
How they compare
Myanmar currently reports 23.8% against 22.6% in Angola, a difference of 1.2%.
That makes Myanmar's figure about 1.1 times Angola's.
The two have swapped places 4 times across 9 shared years of data; in 2016 it was Myanmar ahead.
Angola ranks 49th and Myanmar ranks 48th of 66 countries.
Myanmar has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Angola | Myanmar | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 3.7% | 68.0% | 64.3% | Myanmar |
| 2020s | 12.9% | 25.6% | 12.7% | Myanmar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment coverage for lymphatic filariasis, Angola or Myanmar?
- Myanmar, at 23.8% against 22.6% in Angola as of 2024.
- What is the difference in treatment coverage for lymphatic filariasis between Angola and Myanmar?
- 1.2%, with Myanmar ahead.
- How many years of comparable data are there for Angola and Myanmar?
- 9 years are reported by both, from 2016 to 2024.
- How do Angola and Myanmar rank globally for treatment coverage for lymphatic filariasis?
- Angola ranks 49th and Myanmar ranks 48th of 66 countries.
- Where does this data come from?
- World Health Organization (2025) – with minor processing by Our World in Data, published as Treatment coverage for lymphatic filariasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Drug coverage out of estimated population who require it.